Navigation Links
PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
Date:9/17/2009

Total liabilities 5,985,000 8,373,000 --------- --------- Commitments and contingencies Shareholders' equity: Common shares; no par value; 50,000,000 shares authorized; 9,964,366 shares issued and 9,668,671 outstanding June 30, 2009 9,879,066 shares issued and 9,803,366 outstanding June 30, 2008 16,574,000 16,545,000 Accumulated deficit (6,092,000) (3,247,000) --------- --------- Total shareholders' equity 10,482,000 13,298,000 Total liabilities and shareholders' equity $16,467,000 $21,671,000 =========== =========== See notes to consolidated financial statements. 

                             PRO-DEX, INC. and SUBSIDIARIES
                         CONSOLIDATED STATEMENTS OF OPERATIONS
                                  Years ended June 30

                                                           2009         2008
                                                           ----         ----

    Net sales                                       $21,122,000  $25,126,000

    Cost of sales                                    14,374,000   16,917,000
                                                     ----------   ----------
    Gross profit                                      6,748,000    8,209,000

    Operating expenses:
      Selling expense                                 1,295,000    1,482,000
      General and administrative expenses             3,157,000    3,265,000
      Irvine facility move related general and
       administrative expenses                                -      274,000
      Impairment of intangible
'/>"/>
SOURCE  Pro-Dex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 

Related medicine news :

1. Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Provides Updates on Key Developments
5. American Pacific Announces Executive Change
6. United Way of Greater Los Angeles Announces Matching Fund Launched by Two Local Philanthropists
7. Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants
8. AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media
9. SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test
10. Neogen Corporation Announces 1st Quarter Results Conference Call
11. MDS Announces CEO Transition Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 1Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 2Surgical scrub solution 3A Its good for patients too 56263 1Surgical scrub solution 3A Its good for patients too 56263 2Surgical scrub solution 3A Its good for patients too 56263 3Surgical scrub solution 3A Its good for patients too 56263 4GENova names Dr John Savin as Vice President 56261 1GENova names Dr John Savin as Vice President 56261 2